Hopman Mark
Beta Bionics, Inc. · Chief Commercial Officer
Hopman Mark is listed in filings as Chief Commercial Officer at Beta Bionics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Beta Bionics, Inc. (BBNX). The current snapshot covers public activity from Jun 4, 2025 to Jun 5, 2026. Reported amounts are shown as $3.4K to $4.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3.4k275 shares | SellJun 4, 2026 | $12.31 | $16.90 |